$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

$gbcs Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000149315222024093 Filed on August 26, 2022

Income Statement

Concept	2022 Q3	2021 Q4	2021
Revenue	$9.582M	$10.19M	$29.29M
YoY Change	30.92%	81.17%	39.94%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$9.451M	$10.91M	$28.28M
YoY Change	53.74%	115.81%	79.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$453.6K	$447.1K	$1.733M
YoY Change	4.28%	10.28%	9.68%
% of Gross Profit
Operating Expenses	$9.904M	$11.36M	$30.02M
YoY Change	50.47%	107.97%	71.0%
Operating Profit	-$322.3K		-$729.0K
YoY Change	-143.75%		-121.6%
Interest Expense	$722.2K	-$817.4K	$2.498M
YoY Change	-248.36%	61.1%	16.73%
% of Operating Profit
Other Income/Expense, Net	-$668.6K	$85.59K	-$1.512M
YoY Change	-1389.33%	-18310.64%	266.58%
Pretax Income	-$990.9K	-$1.768M	-$2.241M
YoY Change	1770.03%	-235.2%	-175.66%
Income Tax
% Of Pretax Income
Net Earnings	-$990.9K	-$1.768M	-$2.252M
YoY Change	1770.02%	-235.55%	-176.19%
Net Earnings / Revenue	-10.34%	-17.35%	-7.69%
Basic Earnings Per Share	-$0.33		-$0.82
Diluted Earnings Per Share	-$0.33	-$620.5K	-$0.82
COMMON SHARES
Basic Shares Outstanding	3.067M shares		2.768M shares
Diluted Shares Outstanding	3.055M shares		2.768M shares

Balance Sheet

Concept	2022 Q3	2021 Q4	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.953M	$3.964M	$3.964M
YoY Change	-30.65%	11.11%	11.11%
Cash & Equivalents	$2.760M	$3.939M	$3.939M
Short-Term Investments	$24.39K	$24.39K	$24.39K
Other Short-Term Assets	$462.9K	$498.0K	$498.0K
YoY Change	-60.07%
Inventory
Prepaid Expenses
Receivables	$3.065M	$3.507M	$3.507M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.481M	$7.969M	$7.969M
YoY Change	-34.86%	28.39%	44.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.01M	$37.02M	$37.02M
YoY Change	-3.84%	-3.17%	-3.17%
Goodwill	$1.077M	$1.077M
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$831.7K	$853.7K	$853.7K
YoY Change		-21.96%	-21.96%
Total Long-Term Assets	$37.92M	$38.96M	$38.96M
YoY Change	-1.58%	-1.94%	-3.66%
TOTAL ASSETS
Total Short-Term Assets	$5.481M	$7.969M	$7.969M
Total Long-Term Assets	$37.92M	$38.96M	$38.96M
Total Assets	$43.40M	$46.92M	$46.92M
YoY Change	-7.54%	2.16%	2.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$0.00	$21.57K	$21.57K
YoY Change	-100.0%	117.88%	117.88%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$150.0K	$150.0K	$150.0K
YoY Change	-45.45%
Long-Term Debt Due	$2.050M	$6.313M	$6.313M
YoY Change	-61.23%	-67.29%
Total Short-Term Liabilities	$4.686M	$11.79M	$11.79M
YoY Change	-48.03%	-50.13%	240.16%
LONG-TERM LIABILITIES
Long-Term Debt	$34.53M	$31.05M	$31.80M
YoY Change	0.76%	64.92%	-18.97%
Other Long-Term Liabilities	$253.9K	$229.6K	$229.6K
YoY Change	-1.82%
Total Long-Term Liabilities	$34.53M	$31.05M	$32.03M
YoY Change	0.0%	64.92%	-18.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.686M	$11.79M	$11.79M
Total Long-Term Liabilities	$34.53M	$31.05M	$32.03M
Total Liabilities	$40.22M	$43.82M	$43.82M
YoY Change	-7.64%	2.59%	3.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.54M	-$11.32M
YoY Change		25.25%
Common Stock	$152.7K	$150.2K
YoY Change		11.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.178M	$3.102M	$3.102M
YoY Change
Total Liabilities & Shareholders Equity	$43.40M	$46.92M	$46.92M
YoY Change	-7.54%	2.16%	2.16%

Cashflow Statement

Concept	2022 Q3	2021 Q4	2021
OPERATING ACTIVITIES
Net Income	-$990.9K	-$1.768M	-$2.252M
YoY Change	1770.02%	-235.55%	-176.19%
Depreciation, Depletion And Amortization	$453.6K	$447.1K	$1.733M
YoY Change	4.28%	10.28%	9.68%
Cash From Operating Activities	-$752.1K	$1.334M	-$270.9K
YoY Change	-21.85%	-870.73%	-109.91%
INVESTING ACTIVITIES
Capital Expenditures	-$239.7K	-$25.89K	$519.6K
YoY Change	144.37%	-89.3%	-47.29%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$239.7K	-$25.89K	-$519.6K
YoY Change	144.37%	-89.3%	-66.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$713.6K
YoY Change			-802.64%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-135.1K	-128.7K	$1.605M
YoY Change	-113.67%	-64.45%	-12.01%
NET CHANGE
Cash From Operating Activities	-752.1K	1.334M	-$270.9K
Cash From Investing Activities	-239.7K	-25.89K	-$519.6K
Cash From Financing Activities	-135.1K	-128.7K	$1.605M
Net Change In Cash	-1.127M	1.179M	$814.8K
YoY Change	1462.47%	-251.74%	-72.71%
FREE CASH FLOW
Cash From Operating Activities	-$752.1K	$1.334M	-$270.9K
Capital Expenditures	-$239.7K	-$25.89K	$519.6K
Free Cash Flow	-$512.4K	$1.360M	-$790.5K
YoY Change	-40.72%	1872.61%	-145.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid		usd
CY2021	us-gaap	Acquisition Costs AcquisitionCosts		usd
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000727346
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2020Q4	GBCS	Long Term Debt Related Parties Noncurrent LongTermDebtRelatedPartiesNoncurrent		usd
CY2021	GBCS	Prepaid Deposit Exchanged For Fixed Assets Acquisition PrepaidDepositExchangedForFixedAssetsAcquisition		usd
CY2021	GBCS	Relative Fair Value Of Warrants Issued With Senior Secured Promissory Notes RelativeFairValueOfWarrantsIssuedWithSeniorSecuredPromissoryNotes		usd
CY2021	GBCS	Interest On Debt Capitalized Into Principal InterestOnDebtCapitalizedIntoPrincipal		usd
CY2021	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts		usd
CY2021	GBCS	Exercise Of Stock Options ExerciseOfStockOptions		shares
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2020	GBCS	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPppLoan		usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2020	GBCS	Lease Termination Expense LeaseTerminationExpense		usd
CY2021	GBCS	Cashless Exercise Of Warrants CashlessExerciseOfWarrants		usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2020	GBCS	Gain On Forgiveness From Paycheck Protection Program Loan GainOnForgivenessFromPaycheckProtectionProgramLoan		usd
CY2020	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt		usd
CY2021	GBCS	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2021	GBCS	Net Cash Paid In Fairland Asset Acquisition NetCashPaidInFairlandAssetAcquisition		usd
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2021	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts		usd
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2020	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest		usd
CY2020	GBCS	Proceeds From Debt Discount Warrants ProceedsFromDebtDiscountWarrants		usd
CY2020	GBCS	Payments For Debt Discount Warrants Related Parties PaymentsForDebtDiscountWarrantsRelatedParties		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2020	GBCS	Issuance Of Common Stock For Cashless Exercise Of Warrants IssuanceOfCommonStockForCashlessExerciseOfWarrants		usd
CY2020	GBCS	Issuance Of Common Stock For Cashless Exercise Of Options IssuanceOfCommonStockForCashlessExerciseOfOptions		usd
CY2020	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums		usd
CY2020	GBCS	Exercise Of Stock Options ExerciseOfStockOptions		shares
CY2021	GBCS	Exercise Of Warrants ExerciseOfWarrants		shares
CY2020	GBCS	Exercise Of Warrants ExerciseOfWarrants		shares
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2020Q4	GBCS	Debt Related Parties Net DebtRelatedPartiesNet		usd
CY2021	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-05-31
CY2021Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2021-09-30
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree		usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards		usd
CY2020Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	0-15415
CY2021	dei	Entity Registrant Name EntityRegistrantName	Selectis Health, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	UT
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0340206
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	8480 E Orchard Rd
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste 4900
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80111
CY2021	dei	City Area Code CityAreaCode	(720)
CY2021	dei	Local Phone Number LocalPhoneNumber	680-0808
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	15518992	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3067059	shares
CY2021	dei	Auditor Firm AuditorFirmId	457
CY2020	dei	Auditor Firm AuditorFirmId	206
CY2021	dei	Auditor Name AuditorName	Haynie & Company
CY2021	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2020	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2020	dei	Auditor Location AuditorLocation	Houston, Texas
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3939445	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3567437	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3506719	usd
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1931569	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	498015	usd
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	682949	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	24387	usd
CY2020Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	24387	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7968566	usd
CY2020Q4	us-gaap	Assets Current AssetsCurrent	6206342	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	853656	usd
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	410866	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37024592	usd
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38238367	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	31054962	usd
CY2020Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	39707193	usd
CY2020Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2021Q4	us-gaap	Assets Assets	46923722	usd
CY2020Q4	us-gaap	Assets Assets	45932483	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4363917	usd
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3196178	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	21571	usd
CY2020Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	9900	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7500	usd
CY2020Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7500	usd
CY2021Q4	GBCS	Debt Discount Of Related Parties DebtDiscountOfRelatedParties	0	usd
CY2020Q4	GBCS	Debt Discount Of Related Parties DebtDiscountOfRelatedParties	3234	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	150000	usd
CY2020Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1121766	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1184	usd
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1714	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6312562	usd
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	19299156	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	931446	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11786996	usd
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	23634500	usd
CY2021Q4	GBCS	Debt Instrument Unamortized Discount Related Parties Noncurrent DebtInstrumentUnamortizedDiscountRelatedPartiesNoncurrent	0	usd
CY2020Q4	GBCS	Debt Instrument Unamortized Discount Related Parties Noncurrent DebtInstrumentUnamortizedDiscountRelatedPartiesNoncurrent	0	usd
CY2021Q4	GBCS	Long Term Debt Related Parties Noncurrent LongTermDebtRelatedPartiesNoncurrent	750000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	580912	usd
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	450879	usd
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18830444	usd
CY2021Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	229582	usd
CY2020Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	251600	usd
CY2021Q4	us-gaap	Liabilities Liabilities	43821540	usd
CY2020Q4	us-gaap	Liabilities Liabilities	42716544	usd
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2998361	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2998361	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2686637	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2686637	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	150168	usd
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	134332	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13494394	usd
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11540052	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11318380	usd
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9036400	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3102182	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3413984	usd
CY2020Q4	us-gaap	Minority Interest MinorityInterest	-198045	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3102182	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3215939	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46923722	usd
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45932483	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29287226	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20928698	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	21473397	usd
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	13384322	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5911934	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2088722	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	897538	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	292529	usd
CY2020	us-gaap	Acquisition Costs AcquisitionCosts	207899	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1733349	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1580300	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	30016218	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	17553772	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-728992	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	3374926	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-65623	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1727349	usd
CY2021	us-gaap	Interest Expense InterestExpense	2497893	usd
CY2020	us-gaap	Interest Expense InterestExpense	2139901	usd
CY2021	GBCS	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPppLoan	675598	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	634523	usd
CY2021	GBCS	Lease Termination Expense LeaseTerminationExpense	258943	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1512338	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-412552	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-2241330	usd
CY2020	us-gaap	Profit Loss ProfitLoss	2962374	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10650	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6554	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2251980	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2955820	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	30000	usd
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	30000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2281980	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2925820	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.82
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.07
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.82
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.95
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2768285	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2724753	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2768285	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3107253	shares
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	366650	usd
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	8750	usd
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	30000	usd
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	101563	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	27228	usd
CY2020	us-gaap	Profit Loss ProfitLoss	2962374	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3215939	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	713625	usd
CY2021	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	18650	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	30000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	590000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	60000	usd
CY2021	GBCS	Stock Issued During Period Shares Issued For Loss On Forgiveness Of Debt Net StockIssuedDuringPeriodSharesIssuedForLossOnForgivenessOfDebtNet	50873	shares
CY2021	GBCS	Additional Paid In Capital Modification Of Warrants AdditionalPaidInCapitalModificationOfWarrants	844425	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-2241330	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3102182	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-2241330	usd
CY2020	us-gaap	Profit Loss ProfitLoss	2962374	usd
CY2021	GBCS	Gain On Forgiveness From Paycheck Protection Program Loan GainOnForgivenessFromPaycheckProtectionProgramLoan	-675598	usd
CY2021	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt	-469348	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1733349	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1580300	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	157291	usd
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	121938	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	897538	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	292529	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	18650	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	-8750	usd
CY2020	GBCS	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	1727349	usd
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2472687	usd
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	491881	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-692367	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-136203	usd
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-36107	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2110857	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-95550	usd
CY2021	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-22019	usd
CY2020	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	500	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-270930	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2734207	usd
CY2020	GBCS	Net Cash Paid In Fairland Asset Acquisition NetCashPaidInFairlandAssetAcquisition	74060	usd
CY2020	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	1045767	usd
CY2020	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	532690	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	519575	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	985681	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-519575	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1572818	usd
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100000	usd
CY2021	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	9134102	usd
CY2020	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	3265448	usd
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	8118772	usd
CY2020	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1352300	usd
CY2020	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	57184	usd
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	30000	usd
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	30000	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	713625	usd
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	101563	usd
CY2021	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	60000	usd
CY2021	GBCS	Proceeds From Debt Discount Warrants ProceedsFromDebtDiscountWarrants	34396	usd
CY2021	GBCS	Payments For Debt Discount Warrants Related Parties PaymentsForDebtDiscountWarrantsRelatedParties	68048	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1605303	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1824401	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	814798	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2985790	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3978303	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	992513	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4793101	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3978303	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2497893	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	2018428	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3939445	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3567437	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	853656	usd
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	410866	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4793101	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3978303	usd
CY2021	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	30000	usd
CY2020	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	30000	usd
CY2021	GBCS	Issuance Of Common Stock For Cashless Exercise Of Warrants IssuanceOfCommonStockForCashlessExerciseOfWarrants	976	usd
CY2021	GBCS	Issuance Of Common Stock For Cashless Exercise Of Options IssuanceOfCommonStockForCashlessExerciseOfOptions	1560	usd
CY2021	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums	507433	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	150000	usd
CY2020	GBCS	Noncash Debt Financing For Fixed Assets Purchase NoncashDebtFinancingForFixedAssetsPurchase	784000	usd
CY2020	GBCS	Prepaid Deposit Exchanged For Fixed Assets Acquisition PrepaidDepositExchangedForFixedAssetsAcquisition	117500	usd
CY2020	GBCS	Relative Fair Value Of Warrants Issued With Senior Secured Promissory Notes RelativeFairValueOfWarrantsIssuedWithSeniorSecuredPromissoryNotes	27228	usd
CY2020	GBCS	Interest On Debt Capitalized Into Principal InterestOnDebtCapitalizedIntoPrincipal	5177	usd
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zOhVk6oR2Xlb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zm5dblr2Nczd">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	4810596	usd
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_z9OYH9fxfJSa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zoCwuRv06Sub">Use of Estimates and Assumptions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates included herein relate to the recoverability of assets, the purchase price allocation for properties acquired, and the fair value of certain assets and liabilities. Actual results may differ from estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2021Q4	GBCS	Working Capital Deficit WorkingCapitalDeficit	-3818430	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-2241330	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-1243071	usd
CY2021Q4	us-gaap	Escrow Deposit EscrowDeposit	853656	usd
CY2020Q4	us-gaap	Escrow Deposit EscrowDeposit	410866	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	853656	usd
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	410866	usd
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zJycXUupMduc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zAZqfK0nCn0l">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains deposits in financial institutions that at times exceed the insured amount of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20211231_z1RzdlSEZLsc" title="Cash, FDIC insured amount">250,000</span> provided by the U.S. Federal Deposit Insurance Corporation (FDIC). The excess amounts at December 31, 2021 and 2020 were $<span id="xdx_90F_eus-gaap--CashUninsuredAmount_iI_c20211231_ze8bl8sdiSq5" title="Cash uninsured amount">0</span> and $<span id="xdx_90D_eus-gaap--CashUninsuredAmount_iI_c20201231_z1LHswdXbBbj">2,406,815</span> respectively. The Company went to an Insured Cash Sweep service (ICS) in 2021. ICS funds are eligible for multi-million-dollar FDIC insurance that’s backed by the full faith and credit of the United States government. Daily cash is swept and deposited to as many banks as needed that are FDIC insured. This insures no amounts exceed a $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20211231_zAV0EhR7ES6b">250,000</span> balance which is fully insured by the FDIC. The funds can be tracked by its primary financial institution. New funds can be deposited and withdrawn from that single relationship. The Company believes the financial institutions it uses are credit worthy and stable. The Company does not believe that it is exposed to any significant credit risk in cash and cash equivalents or restricted cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2021Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2406815	usd
CY2021Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-455827	usd
CY2021Q4	GBCS	Debt Less Unamortized Discount DebtLessUnamortizedDiscount	38267524	usd
CY2020	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	57184	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	157291	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	121938	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	19461521	usd
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	589379	usd
CY2020	us-gaap	Straight Line Rent StraightLineRent	36107	usd
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	258943	usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	1901203	usd
CY2020Q4	GBCS	Debt Less Unamortized Discount DebtLessUnamortizedDiscount	39251366	usd
CY2021Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	39510595	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2251980	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2955820	usd
CY2021	GBCS	Preferred Stock Dividends And Other Adjustments Basic PreferredStockDividendsAndOtherAdjustmentsBasic	30000	usd
CY2020	GBCS	Preferred Stock Dividends And Other Adjustments Basic PreferredStockDividendsAndOtherAdjustmentsBasic	30000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2281980	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2925820	usd
CY2021	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	2251980	usd
CY2020	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	2925820	usd
CY2021	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	-30000	usd
CY2020	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	-30000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2281980	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2955820	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2768285	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2724753	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2768285	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2724753	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	382500	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2768285	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3107253	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.82
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.07
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.82
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.95
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue	24387	usd
CY2020Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue	24387	usd
CY2020Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue	24387	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49004003	usd
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	48484429	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10419411	usd
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8686062	usd
CY2021Q4	GBCS	Impairment Impairment	1560000	usd
CY2020Q4	GBCS	Impairment Impairment	1560000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37024592	usd
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38238367	usd
CY2021	us-gaap	Depreciation Depreciation	1733349	usd
CY2020	us-gaap	Depreciation Depreciation	1546029	usd
CY2021	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	519575	usd
CY2020	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	985681	usd
CY2021Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	39510595	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	6312562	usd
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	19299156	usd
CY2021Q4	us-gaap	Debt Current DebtCurrent	150000	usd
CY2020Q4	us-gaap	Debt Current DebtCurrent	1121766	usd
CY2021Q4	GBCS	Debt Current And Non Current DebtCurrentAndNonCurrent	31054962	usd
CY2020Q4	GBCS	Debt Current And Non Current DebtCurrentAndNonCurrent	18830444	usd
CY2021Q4	GBCS	Debt Related Parties Net DebtRelatedPartiesNet	750000	usd
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	5177	usd
CY2021Q4	GBCS	Incremental Increase In Fair Value Of Debt Discount IncrementalIncreaseInFairValueOfDebtDiscount	844425	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	27228	usd
CY2021	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	521400	usd
CY2021Q4	GBCS	Mortgage One MortgageOne	2961167	usd
CY2021Q4	GBCS	Mortgage Two MortgageTwo	3289595	usd
CY2021Q3	GBCS	Mortgage One MortgageOne	2065969	usd
CY2021Q3	GBCS	Mortgage Two MortgageTwo	750000	usd
CY2021Q3	GBCS	Mortgage Three MortgageThree	500000	usd
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P35Y
CY2021Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0238	pure
CY2021Q4	us-gaap	Notes Payable NotesPayable	1980000	usd
CY2020Q4	us-gaap	Notes Payable NotesPayable	2670000	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	9134102	usd
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	3365448	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2728599	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6248456	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	8118772	usd
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1352300	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	157296	usd
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	121938	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6261423	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	931446	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	931446.00	usd
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	30000	usd
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	30000	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	3000	shares
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	18750	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	150000	shares
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.00
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	713625	usd
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	10000	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	60000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.60
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	102000	usd
CY2020	GBCS	Directors Fee DirectorsFee	7500	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	55116	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3272970	usd
CY2020Q4	GBCS	Deferred Tax Liabilities Bargain Purchase Gain DeferredTaxLiabilitiesBargainPurchaseGain	-1020000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	626808	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	635026	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	643401	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	651954	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	660665	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.21	pure
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2523460	usd
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1930927	usd
CY2021Q4	GBCS	Impairment Loss On Long Term Assets Impairment Loss On Long Term Assets ImpairmentLossOnLongTermAssetsImpairmentLossOnLongTermAssets	327600	usd
CY2020Q4	GBCS	Impairment Loss On Long Term Assets Impairment Loss On Long Term Assets ImpairmentLossOnLongTermAssetsImpairmentLossOnLongTermAssets	327600	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	595154	usd
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	595154	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	31387	usd
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	31387	usd
CY2021Q4	GBCS	Deferred Tax Assets Acquisition Costs DeferredTaxAssetsAcquisitionCosts	124304	usd
CY2020Q4	GBCS	Deferred Tax Assets Acquisition Costs DeferredTaxAssetsAcquisitionCosts	167963	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	625496	usd
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	618072	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4227401	usd
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3671103	usd
CY2021Q4	GBCS	Deferred Tax Liabilities Bargain Purchase Gain DeferredTaxLiabilitiesBargainPurchaseGain	-1020000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	380902	usd
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	364122	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1400902	usd
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1384122	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2826499	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2286981	usd
CY2021Q4	GBCS	Future Taxable Income FutureTaxableIncome	13500000	usd
CY2021	GBCS	Net Operating Loss Carryforward Expiry NetOperatingLossCarryforwardExpiry	beginning in 2020
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1500000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2019Q4	us-gaap	Goodwill Goodwill	379479	usd
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	697429	usd
CY2020Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	integer

Files In Submission

Name	View Source	Status
0001493152-22-024093-index-headers.html	Edgar Link	pending
0001493152-22-024093-index.html	Edgar Link	pending
0001493152-22-024093.txt	Edgar Link	pending
0001493152-22-024093-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
gbcs-20211231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
gbcs-20211231_cal.xml	Edgar Link	unprocessable
gbcs-20211231_pre.xml	Edgar Link	unprocessable
gbcs-20211231_lab.xml	Edgar Link	unprocessable
gbcs-20211231_def.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

2022 Q3 Form 10-K Financial Statement

#000149315222024093 Filed on August 26, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS SELECTIS HEALTH, INC. Stock $gbcs

2022 Q3 Form 10-K Financial Statement

#000149315222024093 Filed on August 26, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs